| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | pyrophosphatase activity | MYH7 ATP7A MYO5B RNF112 DNAH2 RGS9 ENPP4 GTPBP10 ABCA7 ABCA8 GTPBP2 ABCA6 ATP2C2 ABCD3 GNL2 DNM3 ASCC3 DNM1 RAB26 | 5.69e-05 | 839 | 163 | 19 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | MYH7 ATP7A MYO5B RNF112 DNAH2 RGS9 ENPP4 GTPBP10 ABCA7 ABCA8 GTPBP2 ABCA6 ATP2C2 ABCD3 GNL2 DNM3 ASCC3 DNM1 RAB26 | 5.78e-05 | 840 | 163 | 19 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | MYH7 ATP7A MYO5B RNF112 DNAH2 RGS9 ENPP4 GTPBP10 ABCA7 ABCA8 GTPBP2 ABCA6 ATP2C2 ABCD3 GNL2 DNM3 ASCC3 DNM1 RAB26 | 5.78e-05 | 840 | 163 | 19 | GO:0016818 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | MYH7 ATP7A MYO5B RNF112 DNAH2 RGS9 GTPBP10 ABCA7 ABCA8 GTPBP2 ABCA6 ATP2C2 ABCD3 GNL2 DNM3 ASCC3 DNM1 RAB26 | 6.55e-05 | 775 | 163 | 18 | GO:0017111 |
| GeneOntologyMolecularFunction | retinoic acid binding | 7.52e-05 | 28 | 163 | 4 | GO:0001972 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 1.09e-04 | 178 | 163 | 8 | GO:0015399 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 1.22e-04 | 231 | 163 | 9 | GO:0005085 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC24A5 ATP7A SLC35C2 NDUFB8 ABCA7 ABCA8 NDUFS2 SLC2A4 ABCA6 SLC20A1 SLC20A2 ATP2C2 ABCD3 | 1.53e-04 | 477 | 163 | 13 | GO:0022804 |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH7 SETX ATP7A MYO5B DNAH2 KIF4A NUBPL ABCA7 ABCA8 DNAH14 ABCA6 ATP2C2 ABCD3 ASCC3 SLC27A4 | 1.58e-04 | 614 | 163 | 15 | GO:0140657 |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 1.84e-04 | 35 | 163 | 4 | GO:0015020 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 2.73e-04 | 109 | 163 | 6 | GO:0042626 | |
| GeneOntologyMolecularFunction | retinoid binding | 6.30e-04 | 48 | 163 | 4 | GO:0005501 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC24A5 ATP7A ANXA6 SLC35C2 GRID1 GRIK5 GRM7 NDUFB8 ABCA7 ABCA8 NDUFS2 SLC2A4 SLC2A5 ANO8 ABCA6 ANO6 SLC20A1 SLC20A2 ATP2C2 ABCD3 SLC27A4 | 6.33e-04 | 1180 | 163 | 21 | GO:0022857 |
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 6.52e-04 | 5 | 163 | 2 | GO:0140444 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 6.81e-04 | 49 | 163 | 4 | GO:0140359 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 6.81e-04 | 49 | 163 | 4 | GO:0019840 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H | 1.09e-03 | 95 | 163 | 5 | GO:0016651 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 1.16e-03 | 196 | 163 | 7 | GO:0005319 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 1.35e-03 | 27 | 163 | 3 | GO:0008066 | |
| GeneOntologyBiologicalProcess | biphenyl catabolic process | 2.76e-07 | 8 | 166 | 4 | GO:0070980 | |
| GeneOntologyBiologicalProcess | biphenyl metabolic process | 8.18e-07 | 10 | 166 | 4 | GO:0018879 | |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 1.90e-06 | 12 | 166 | 4 | GO:0052697 | |
| GeneOntologyBiologicalProcess | benzene-containing compound metabolic process | 1.12e-05 | 37 | 166 | 5 | GO:0042537 | |
| GeneOntologyBiologicalProcess | androgen metabolic process | 1.29e-05 | 38 | 166 | 5 | GO:0008209 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 2.18e-05 | 21 | 166 | 4 | GO:0052695 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 5.27e-05 | 26 | 166 | 4 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 5.27e-05 | 26 | 166 | 4 | GO:0006063 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 6.09e-05 | 52 | 166 | 5 | GO:0008210 | |
| GeneOntologyBiologicalProcess | maintenance of protein complex location | 6.44e-05 | 2 | 166 | 2 | GO:0098544 | |
| GeneOntologyBiologicalProcess | synaptic vesicle budding from presynaptic endocytic zone membrane | 8.06e-05 | 11 | 166 | 3 | GO:0016185 | |
| GeneOntologyCellularComponent | nuclear outer membrane | 7.03e-07 | 40 | 166 | 6 | GO:0005640 | |
| Domain | P-loop_NTPase | MYH7 NWD1 SETX MYO5B RNF112 DNAH2 KIF4A HNRNPUL1 NUBPL GTPBP10 ABCA7 ABCA8 DNAH14 GTPBP2 NOD1 ABCA6 ABCD3 GNL2 DNM3 ASCC3 DNM1 RAB26 | 6.38e-06 | 848 | 166 | 22 | IPR027417 |
| Domain | - | 1.35e-05 | 6 | 166 | 3 | 2.140.10.10 | |
| Domain | Quinoprotein_ADH-like_fam | 1.35e-05 | 6 | 166 | 3 | IPR027295 | |
| Domain | UDPGT | 3.20e-05 | 21 | 166 | 4 | PF00201 | |
| Domain | UDPGT | 3.20e-05 | 21 | 166 | 4 | PS00375 | |
| Domain | UDP_glucos_trans | 3.20e-05 | 21 | 166 | 4 | IPR002213 | |
| Domain | - | NWD1 SETX RNF112 DNAH2 HNRNPUL1 NUBPL GTPBP10 ABCA7 ABCA8 DNAH14 GTPBP2 NOD1 ABCA6 ABCD3 GNL2 DNM3 ASCC3 DNM1 RAB26 | 3.68e-05 | 746 | 166 | 19 | 3.40.50.300 |
| Domain | Phos_transporter | 7.85e-05 | 2 | 166 | 2 | IPR001204 | |
| Domain | PHO4 | 7.85e-05 | 2 | 166 | 2 | PF01384 | |
| Domain | Quinoprotein_ADH-like_supfam | 1.06e-04 | 53 | 166 | 5 | IPR011047 | |
| Domain | ABC_A | 1.43e-04 | 12 | 166 | 3 | IPR026082 | |
| Domain | WD_REPEATS_1 | NWD1 WDR33 GEMIN5 PAAF1 WDFY4 DENND3 NBEAL2 HERC1 CFAP44 RIC1 | 1.97e-04 | 278 | 166 | 10 | PS00678 |
| Domain | WD_REPEATS_2 | NWD1 WDR33 GEMIN5 PAAF1 WDFY4 DENND3 NBEAL2 HERC1 CFAP44 RIC1 | 2.02e-04 | 279 | 166 | 10 | PS50082 |
| Domain | WD_REPEATS_REGION | NWD1 WDR33 GEMIN5 PAAF1 WDFY4 DENND3 NBEAL2 HERC1 CFAP44 RIC1 | 2.02e-04 | 279 | 166 | 10 | PS50294 |
| Domain | KEN_dom | 2.34e-04 | 3 | 166 | 2 | IPR010513 | |
| Domain | PQQ | 2.34e-04 | 3 | 166 | 2 | PF01011 | |
| Domain | Ribonuc_2-5A | 2.34e-04 | 3 | 166 | 2 | PF06479 | |
| Domain | KEN | 2.34e-04 | 3 | 166 | 2 | PS51392 | |
| Domain | ANF_lig-bd_rcpt | 3.16e-04 | 37 | 166 | 4 | IPR001828 | |
| Domain | ANF_receptor | 3.16e-04 | 37 | 166 | 4 | PF01094 | |
| Domain | WD40_repeat_dom | NWD1 WDR33 GEMIN5 PAAF1 WDFY4 DENND3 NBEAL2 HERC1 CFAP44 RIC1 | 3.33e-04 | 297 | 166 | 10 | IPR017986 |
| Domain | Peripla_BP_I | 3.88e-04 | 39 | 166 | 4 | IPR028082 | |
| Domain | Pecanex_C | 4.66e-04 | 4 | 166 | 2 | PF05041 | |
| Domain | KASH | 4.66e-04 | 4 | 166 | 2 | IPR012315 | |
| Domain | KASH | 4.66e-04 | 4 | 166 | 2 | PS51049 | |
| Domain | DUF846 | 4.66e-04 | 4 | 166 | 2 | PF05832 | |
| Domain | KASH | 4.66e-04 | 4 | 166 | 2 | SM01249 | |
| Domain | KASH | 4.66e-04 | 4 | 166 | 2 | PF10541 | |
| Domain | DUF846_euk | 4.66e-04 | 4 | 166 | 2 | IPR008564 | |
| Domain | Pecanex | 4.66e-04 | 4 | 166 | 2 | IPR007735 | |
| Domain | WD40 | 5.27e-04 | 259 | 166 | 9 | PF00400 | |
| Domain | WD40_repeat_CS | 6.68e-04 | 164 | 166 | 7 | IPR019775 | |
| Domain | WD40 | 6.73e-04 | 268 | 166 | 9 | SM00320 | |
| Domain | WD40_repeat | 7.48e-04 | 272 | 166 | 9 | IPR001680 | |
| Domain | PUG | 7.72e-04 | 5 | 166 | 2 | SM00580 | |
| Domain | - | NWD1 WDR33 GEMIN5 PAAF1 WDFY4 DENND3 NBEAL2 HERC1 CFAP44 RIC1 | 8.11e-04 | 333 | 166 | 10 | 2.130.10.10 |
| Domain | WD40/YVTN_repeat-like_dom | NWD1 WDR33 GEMIN5 PAAF1 WDFY4 DENND3 NBEAL2 HERC1 CFAP44 RIC1 | 8.49e-04 | 335 | 166 | 10 | IPR015943 |
| Domain | ABC_tran | 8.64e-04 | 48 | 166 | 4 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 8.64e-04 | 48 | 166 | 4 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 9.34e-04 | 49 | 166 | 4 | PS00211 | |
| Domain | ABC_transporter-like | 1.01e-03 | 50 | 166 | 4 | IPR003439 | |
| Domain | Spectrin | 1.07e-03 | 23 | 166 | 3 | PF00435 | |
| Domain | Dynamin_central | 1.15e-03 | 6 | 166 | 2 | IPR000375 | |
| Domain | PQQ | 1.15e-03 | 6 | 166 | 2 | SM00564 | |
| Domain | GED | 1.15e-03 | 6 | 166 | 2 | SM00302 | |
| Domain | Dynamin_M | 1.15e-03 | 6 | 166 | 2 | PF01031 | |
| Domain | GED_dom | 1.15e-03 | 6 | 166 | 2 | IPR020850 | |
| Domain | PUB_domain | 1.15e-03 | 6 | 166 | 2 | IPR018997 | |
| Domain | PQQ_repeat | 1.15e-03 | 6 | 166 | 2 | IPR002372 | |
| Domain | PQQ_beta_propeller_repeat | 1.15e-03 | 6 | 166 | 2 | IPR018391 | |
| Domain | GED | 1.15e-03 | 6 | 166 | 2 | PS51388 | |
| Domain | Dynamin_GTPase_CS | 1.15e-03 | 6 | 166 | 2 | IPR019762 | |
| Domain | GED | 1.15e-03 | 6 | 166 | 2 | PF02212 | |
| Domain | GED | 1.15e-03 | 6 | 166 | 2 | IPR003130 | |
| Domain | - | 1.60e-03 | 7 | 166 | 2 | 3.30.390.30 | |
| Domain | G_DYNAMIN_1 | 1.60e-03 | 7 | 166 | 2 | PS00410 | |
| Domain | DYNc | 1.60e-03 | 7 | 166 | 2 | SM00053 | |
| Domain | AAA | 1.83e-03 | 144 | 166 | 6 | SM00382 | |
| Domain | AAA+_ATPase | 1.83e-03 | 144 | 166 | 6 | IPR003593 | |
| Domain | Pyr_nucl-diS_OxRdtase_dimer | 2.12e-03 | 8 | 166 | 2 | IPR004099 | |
| Domain | FAD/NAD-linked_Rdtase_dimer | 2.12e-03 | 8 | 166 | 2 | IPR016156 | |
| Domain | PH-BEACH_dom | 2.12e-03 | 8 | 166 | 2 | IPR023362 | |
| Domain | - | 2.12e-03 | 8 | 166 | 2 | 2.30.29.40 | |
| Domain | PH_BEACH | 2.12e-03 | 8 | 166 | 2 | PS51783 | |
| Domain | Spectrin_repeat | 2.13e-03 | 29 | 166 | 3 | IPR002017 | |
| Domain | BEACH | 2.71e-03 | 9 | 166 | 2 | PS50197 | |
| Domain | Beach | 2.71e-03 | 9 | 166 | 2 | PF02138 | |
| Domain | - | 2.71e-03 | 9 | 166 | 2 | 1.10.1540.10 | |
| Domain | Beach | 2.71e-03 | 9 | 166 | 2 | SM01026 | |
| Domain | BEACH_dom | 2.71e-03 | 9 | 166 | 2 | IPR000409 | |
| Domain | SPEC | 2.83e-03 | 32 | 166 | 3 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.83e-03 | 32 | 166 | 3 | IPR018159 | |
| Domain | ARM-like | 2.91e-03 | 270 | 166 | 8 | IPR011989 | |
| Domain | Anoctamin | 3.37e-03 | 10 | 166 | 2 | PF04547 | |
| Domain | Anoctamin | 3.37e-03 | 10 | 166 | 2 | IPR007632 | |
| Domain | E3_UB_ligase_RBR | 3.37e-03 | 10 | 166 | 2 | IPR031127 | |
| Domain | Dynein_heavy_chain_D4_dom | 6.66e-03 | 14 | 166 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 6.66e-03 | 14 | 166 | 2 | IPR024743 | |
| Domain | G_DYNAMIN_dom | 6.66e-03 | 14 | 166 | 2 | IPR030381 | |
| Domain | IBR | 6.66e-03 | 14 | 166 | 2 | PF01485 | |
| Domain | Sugar/inositol_transpt | 6.66e-03 | 14 | 166 | 2 | IPR003663 | |
| Domain | IBR | 6.66e-03 | 14 | 166 | 2 | SM00647 | |
| Domain | MT | 6.66e-03 | 14 | 166 | 2 | PF12777 | |
| Domain | AAA_8 | 6.66e-03 | 14 | 166 | 2 | PF12780 | |
| Domain | GPCR_3_CS | 6.66e-03 | 14 | 166 | 2 | IPR017979 | |
| Domain | CNH | 6.66e-03 | 14 | 166 | 2 | SM00036 | |
| Domain | G_DYNAMIN_2 | 6.66e-03 | 14 | 166 | 2 | PS51718 | |
| Domain | SH3_2 | 7.26e-03 | 86 | 166 | 4 | PF07653 | |
| Domain | SH3_2 | 7.26e-03 | 86 | 166 | 4 | IPR011511 | |
| Domain | DHC_fam | 7.64e-03 | 15 | 166 | 2 | IPR026983 | |
| Domain | Dynamin_GTPase | 7.64e-03 | 15 | 166 | 2 | IPR001401 | |
| Domain | Peptidase_C2 | 7.64e-03 | 15 | 166 | 2 | PF00648 | |
| Domain | Dynamin_SF | 7.64e-03 | 15 | 166 | 2 | IPR022812 | |
| Domain | uDENN | 7.64e-03 | 15 | 166 | 2 | PF03456 | |
| Domain | Dynein_heavy | 7.64e-03 | 15 | 166 | 2 | PF03028 | |
| Domain | CysPc | 7.64e-03 | 15 | 166 | 2 | SM00230 | |
| Domain | IBR_dom | 7.64e-03 | 15 | 166 | 2 | IPR002867 | |
| Domain | Peptidase_C2_calpain_cat | 7.64e-03 | 15 | 166 | 2 | IPR001300 | |
| Domain | Dynamin_N | 7.64e-03 | 15 | 166 | 2 | PF00350 | |
| Domain | CNH | 7.64e-03 | 15 | 166 | 2 | PF00780 | |
| Pathway | REACTOME_PREDNISONE_ADME | 5.34e-05 | 23 | 130 | 4 | MM16639 | |
| Pathway | REACTOME_GLUCURONIDATION | 6.36e-05 | 24 | 130 | 4 | MM14599 | |
| Pathway | REACTOME_GLUCURONIDATION | 7.52e-05 | 25 | 130 | 4 | M17787 | |
| Pathway | WP_GLUCURONIDATION | 7.52e-05 | 25 | 130 | 4 | MM15820 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 7.52e-05 | 25 | 130 | 4 | M605 | |
| Pathway | WP_GLUCURONIDATION | 8.82e-05 | 26 | 130 | 4 | M39404 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 1.13e-04 | 52 | 130 | 5 | M14171 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 1.19e-04 | 28 | 130 | 4 | M19580 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 1.48e-04 | 55 | 130 | 5 | M14933 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 4.42e-04 | 39 | 130 | 4 | MM15695 | |
| Pathway | REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | 4.74e-04 | 17 | 130 | 3 | MM14552 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 5.37e-04 | 41 | 130 | 4 | M7399 | |
| Pathway | REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | 5.65e-04 | 18 | 130 | 3 | M524 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 7.04e-04 | 44 | 130 | 4 | M11911 | |
| Pathway | REACTOME_ASPIRIN_ADME | 7.04e-04 | 44 | 130 | 4 | M45014 | |
| Pathway | REACTOME_ASPIRIN_ADME | 7.68e-04 | 45 | 130 | 4 | MM15694 | |
| Pathway | REACTOME_SODIUM_COUPLED_PHOSPHATE_COTRANSPORTERS | 8.29e-04 | 5 | 130 | 2 | M27345 | |
| Pathway | WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE | 8.29e-04 | 5 | 130 | 2 | M46464 | |
| Pathway | REACTOME_SODIUM_COUPLED_PHOSPHATE_COTRANSPORTERS | 8.29e-04 | 5 | 130 | 2 | MM15085 | |
| Pubmed | 1.77e-08 | 7 | 167 | 4 | 26074487 | ||
| Pubmed | 3.54e-08 | 8 | 167 | 4 | 32093886 | ||
| Pubmed | 3.54e-08 | 8 | 167 | 4 | 18719240 | ||
| Pubmed | 3.54e-08 | 8 | 167 | 4 | 20142249 | ||
| Pubmed | 1.09e-07 | 3 | 167 | 3 | 29138287 | ||
| Pubmed | 1.09e-07 | 3 | 167 | 3 | 7835904 | ||
| Pubmed | 1.09e-07 | 3 | 167 | 3 | 23223495 | ||
| Pubmed | THOC1 TPP2 HK2 MARK3 ANXA6 POLRMT GEMIN5 HNRNPUL1 NUBPL GTPBP10 NDUFS2 NKRF AIFM1 SURF6 SYNE2 ABCD3 GNL2 TMEM209 LRP4 IRF2BPL ASCC3 MRPL9 SLC27A4 HERC5 | 1.14e-07 | 1440 | 167 | 24 | 30833792 | |
| Pubmed | TNIK ATP7A MARK3 SYNE1 POLRMT HNRNPUL1 NDUFB8 NDUFS2 ZC3H7A AIFM1 ANO6 SLC20A1 SURF6 SYNE2 ABCD3 GNL2 TMEM209 PLEKHA5 MARVELD2 ASCC3 MAP4K4 MRPL9 HERC5 PNP | 2.05e-07 | 1487 | 167 | 24 | 33957083 | |
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 2.46e-07 | 12 | 167 | 4 | 20308471 | |
| Pubmed | 4.33e-07 | 4 | 167 | 3 | 26176234 | ||
| Pubmed | MTMR12 SETX HK2 POLRMT NKRF DENND3 MADD GTPBP2 ABCD3 PLEKHA5 DNM1 MAP4K4 CLEC16A RIC1 SLC27A4 | 6.48e-07 | 650 | 167 | 15 | 38777146 | |
| Pubmed | TPP2 NSD2 ANXA6 POLRMT KIF4A GEMIN5 HNRNPUL1 NKRF RIF1 SURF6 SYNE2 GNL2 ASCC3 HERC5 PNP | 6.86e-07 | 653 | 167 | 15 | 22586326 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | THOC1 NSD2 MARK3 POLRMT KIF4A HNRNPUL1 GTPBP10 NKRF ZC3H7A RIF1 AIFM1 SURF6 GNL2 ASCC3 MED17 HERC5 | 8.88e-07 | 759 | 167 | 16 | 35915203 |
| Pubmed | 1.08e-06 | 5 | 167 | 3 | 15318931 | ||
| Pubmed | 1.56e-06 | 225 | 167 | 9 | 12168954 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PCNX3 TRIO NSD2 POLRMT GEMIN5 GRID1 NUBPL ABCA7 MADD ANO8 NBEAL2 SURF6 LRP4 PCNX1 HERC1 DNMBP TTC38 ZNF426 RIC1 | 1.70e-06 | 1105 | 167 | 19 | 35748872 |
| Pubmed | 2.15e-06 | 6 | 167 | 3 | 21365123 | ||
| Pubmed | 4.64e-06 | 193 | 167 | 8 | 19343046 | ||
| Pubmed | TNIK MTMR12 MARK3 SYNE1 PPM1E MADD EPG5 FEM1B KIRREL3 DNM3 CLEC16A | 4.86e-06 | 407 | 167 | 11 | 12693553 | |
| Pubmed | 5.98e-06 | 8 | 167 | 3 | 22579593 | ||
| Pubmed | 5.98e-06 | 8 | 167 | 3 | 10748067 | ||
| Pubmed | Nuclear membrane proteins with potential disease links found by subtractive proteomics. | 1.27e-05 | 10 | 167 | 3 | 12958361 | |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | TNIK ATP7A PCNX3 MARK3 ANO6 SLC20A1 SLC20A2 PLEKHA5 MAP4K4 FERMT3 | 1.56e-05 | 377 | 167 | 10 | 38117590 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | THOC1 HK2 TRIO NSD2 SYNE1 ANXA6 POLRMT GEMIN5 HNRNPUL1 NDUFS2 TSFM CRKL RIF1 AIFM1 ABCD3 GNL2 PKP1 MAP4K4 SLC27A4 MGAM2 | 1.81e-05 | 1425 | 167 | 20 | 30948266 |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | TPP2 MYO5B NSD2 MARK3 ZC3H7A ANO6 SURF6 GNL2 INTS4 PLEKHA5 IL17RA FUCA2 ASCC3 SLC27A4 | 1.83e-05 | 754 | 167 | 14 | 33060197 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | THOC1 SETX WDR33 NSD2 SYNE1 ANXA6 HNRNPUL1 NDUFS2 NKRF SURF6 ABCD3 GNL2 DNM3 INTS4 DNM1 MED17 MAP4K4 | 1.97e-05 | 1082 | 167 | 17 | 38697112 |
| Pubmed | Phosphate-dependent FGF23 secretion is modulated by PiT2/Slc20a2. | 2.29e-05 | 2 | 167 | 2 | 29551636 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 27829216 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 23968976 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 10222050 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 22315414 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 32660355 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 11792814 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 21586110 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 9207791 | ||
| Pubmed | Nesprin-1 and nesprin-2 regulate endothelial cell shape and migration. | 2.29e-05 | 2 | 167 | 2 | 24931616 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 12205090 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 28962835 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 1909870 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 24121496 | ||
| Pubmed | Dynamin is primed at endocytic sites for ultrafast endocytosis. | 2.29e-05 | 2 | 167 | 2 | 35809574 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 17263731 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 24267955 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 22170718 | ||
| Pubmed | A family of retroviruses that utilize related phosphate transporters for cell entry. | 2.29e-05 | 2 | 167 | 2 | 7966619 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 24963135 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 22900086 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 24216110 | ||
| Pubmed | Translational control by the ER transmembrane kinase/ribonuclease IRE1 under ER stress. | 2.29e-05 | 2 | 167 | 2 | 11175748 | |
| Pubmed | Slc20a1/Pit1 and Slc20a2/Pit2 are essential for normal skeletal myofiber function and survival. | 2.29e-05 | 2 | 167 | 2 | 32080237 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 27774654 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 12020828 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 15319348 | ||
| Pubmed | Localization of UDP glucuronosyltransferase gene(s) on mouse chromosome 5. | 2.29e-05 | 2 | 167 | 2 | 3105095 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 17848572 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 26302298 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 27496708 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 17494632 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 8041748 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 16790504 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 17698910 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 22768332 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 18036184 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 38195526 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 24673776 | ||
| Pubmed | Syne-1 and Syne-2 play crucial roles in myonuclear anchorage and motor neuron innervation. | 2.29e-05 | 2 | 167 | 2 | 17267447 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 17687269 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 20700106 | ||
| Pubmed | Nesprins: tissue-specific expression of epsilon and other short isoforms. | 2.29e-05 | 2 | 167 | 2 | 24718612 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 24586179 | ||
| Pubmed | Mouse UDP glucuronosyltransferase. cDNA and complete amino acid sequence and regulation. | 2.29e-05 | 2 | 167 | 2 | 3117546 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 38641407 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 12433679 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 17761684 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 31578382 | ||
| Pubmed | Inorganic phosphate regulates Glvr-1 and -2 expression: role of calcium and ERK1/2. | 2.29e-05 | 2 | 167 | 2 | 19232318 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 16581782 | ||
| Pubmed | A multiscale study of the role of dynamin in the regulation of glucose uptake. | 2.29e-05 | 2 | 167 | 2 | 28853753 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 22308498 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 28228532 | ||
| Pubmed | RNase domains determine the functional difference between IRE1alpha and IRE1beta. | 2.29e-05 | 2 | 167 | 2 | 18242182 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 15666817 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 16950141 | ||
| Pubmed | 2.32e-05 | 12 | 167 | 3 | 18161889 | ||
| Pubmed | DOCK2 MYO5B ALPK1 ENPP4 WDFY4 ABCA8 DENND3 ANO8 RASGRP3 IRF2BPL RIC1 | 2.88e-05 | 493 | 167 | 11 | 15368895 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | HK2 LYPLAL1 WDR33 SYNE1 POLRMT HNRNPUL1 NUBPL GTPBP10 NDUFB8 NDUFS2 NKRF TSFM AIFM1 SURF6 SYNE2 ABCD3 GNL2 TMEM209 HERC1 MRPL9 | 3.59e-05 | 1496 | 167 | 20 | 32877691 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | THOC1 MYO5B SYNE1 ANXA6 HNRNPUL1 NKRF CRKL RIF1 AIFM1 SLC20A1 SYNE2 ABCD3 GNL2 PKP1 ASCC3 MAP4K4 | 3.73e-05 | 1024 | 167 | 16 | 24711643 |
| Pubmed | TPP2 MTMR12 TRIO MYO5B NSD2 PPM1E PAAF1 MADD RIF1 AIFM1 SYNE2 ABCD3 GNL2 INTS4 MARVELD2 HERC1 | 4.97e-05 | 1049 | 167 | 16 | 27880917 | |
| Pubmed | DOCK2 ATP7A HK2 ANXA6 KIF4A GEMIN5 ENPP4 ITGAX ANO6 NBEAL2 ABCD3 GNL2 PLEKHA5 ASCC3 MED17 SLC27A4 FERMT3 | 5.11e-05 | 1168 | 167 | 17 | 19946888 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | POLRMT GEMIN5 HNRNPUL1 NKRF AIFM1 ABCD3 GNL2 TMEM209 ASCC3 MED17 | 5.74e-05 | 440 | 167 | 10 | 34244565 |
| Pubmed | 5.82e-05 | 16 | 167 | 3 | 24470103 | ||
| Pubmed | THOC1 TPP2 HK2 TRIO MYO5B POLRMT NDUFS2 NKRF PKP1 LOXL4 MRPL9 SLC27A4 | 6.13e-05 | 634 | 167 | 12 | 34591612 | |
| Pubmed | 6.85e-05 | 3 | 167 | 2 | 11850408 | ||
| Pubmed | 6.85e-05 | 3 | 167 | 2 | 19572376 | ||
| Pubmed | 6.85e-05 | 3 | 167 | 2 | 29511123 | ||
| Pubmed | 6.85e-05 | 3 | 167 | 2 | 26385605 | ||
| Pubmed | The inner nuclear membrane protein Sun1 mediates the anchorage of Nesprin-2 to the nuclear envelope. | 6.85e-05 | 3 | 167 | 2 | 16079285 | |
| Pubmed | 6.85e-05 | 3 | 167 | 2 | 12511974 | ||
| Pubmed | 6.85e-05 | 3 | 167 | 2 | 16973740 | ||
| Cytoband | 4q13 | 2.23e-07 | 15 | 167 | 4 | 4q13 | |
| Cytoband | 6q24 | 3.63e-04 | 8 | 167 | 2 | 6q24 | |
| Cytoband | 17q24 | 5.81e-04 | 10 | 167 | 2 | 17q24 | |
| Cytoband | 7q32.2 | 5.81e-04 | 10 | 167 | 2 | 7q32.2 | |
| Cytoband | 6q25 | 8.48e-04 | 12 | 167 | 2 | 6q25 | |
| GeneFamily | UDP glucuronosyltransferases | 5.38e-05 | 32 | 118 | 4 | 363 | |
| GeneFamily | WD repeat domain containing | 5.55e-05 | 262 | 118 | 9 | 362 | |
| GeneFamily | ATP binding cassette subfamily A | 9.36e-05 | 14 | 118 | 3 | 805 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 2.51e-04 | 4 | 118 | 2 | 1252 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 1.48e-03 | 9 | 118 | 2 | 1230 | |
| GeneFamily | Anoctamins | 1.84e-03 | 10 | 118 | 2 | 865 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_18H_UP | 5.34e-06 | 198 | 167 | 9 | M4283 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.09e-08 | 193 | 167 | 9 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.62e-08 | 199 | 167 | 9 | b0a906586e58009f5ed9272fc29ba28e49c85ee6 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.09e-07 | 185 | 167 | 8 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.75e-07 | 188 | 167 | 8 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.48e-07 | 191 | 167 | 8 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 7.01e-07 | 193 | 167 | 8 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.01e-07 | 193 | 167 | 8 | 697518bab1338dc441b2d93b410d957e692f20e6 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.29e-07 | 194 | 167 | 8 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | metastatic_Lymph_Node|World / Location, Cell class and cell subclass | 7.29e-07 | 194 | 167 | 8 | af6b5806238a610443564754367e91ce378c4a6d | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.58e-07 | 195 | 167 | 8 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | Control_saline-Epithelial_airway|Control_saline / Treatment groups by lineage, cell group, cell type | 8.50e-07 | 198 | 167 | 8 | e6863238e022ecfb6a8e3f4b7661b376e92c5d8f | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.50e-07 | 198 | 167 | 8 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial|Control_saline / Treatment groups by lineage, cell group, cell type | 8.50e-07 | 198 | 167 | 8 | e7aa42e5fbd42c68f50cda4a8f3aa464c862c007 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Hematologic-leukocyte|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-06 | 148 | 167 | 7 | bbf4933582b50b3412c805de5ed137107c996236 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Hematologic|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-06 | 148 | 167 | 7 | 79e376503a3f9504a1ec5af4a60a09cc80e19059 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Hematologic-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-06 | 148 | 167 | 7 | 6543860e3207a7de92a35bb6004be51287582f7a | |
| ToppCell | Frontal_cortex-Hematopoietic-MICROGLIA|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.38e-06 | 159 | 167 | 7 | 41d2c1e71f6983156f8cc8ec5f69e025e5700f46 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.29e-06 | 167 | 167 | 7 | 3b717d33aaf1ef0869cc4bca8432ba8008875cc5 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.42e-06 | 168 | 167 | 7 | b94b1f37c92e019d01ecfa3b7cc6797b6e4a56ff | |
| ToppCell | NS-moderate-d_0-4-Myeloid-pDC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.83e-06 | 177 | 167 | 7 | de1ffe3df76100d46ca158bdd2fea2ebbd4656b4 | |
| ToppCell | wk_20-22-Hematologic-Meg-ery-Platelet|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.59e-06 | 181 | 167 | 7 | 724efbc200e8388829bc7d81830c2689a95fa838 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.23e-06 | 184 | 167 | 7 | fa4915b0498f3069fd5ef497286445528f75187e | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 6.45e-06 | 185 | 167 | 7 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.68e-06 | 186 | 167 | 7 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.68e-06 | 186 | 167 | 7 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GC_B_cells_in_the_LZ|B_lymphocytes / Location, Cell class and cell subclass | 6.92e-06 | 187 | 167 | 7 | 457eb3791a8c5458d81833e0701ac5a9bfdee2bf | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.42e-06 | 189 | 167 | 7 | 3b48b0d220cc24d5170713d61fa91f5bb6c21841 | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 7.42e-06 | 189 | 167 | 7 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.68e-06 | 190 | 167 | 7 | 3fc9e18c7441c0ae8cda65753cc42d0520f4e116 | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.95e-06 | 191 | 167 | 7 | d4f77c73311d1149466bbfe4adbd6a301946ec90 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.22e-06 | 192 | 167 | 7 | 69758a256386a6ed3a6e2c94c55d59baa34892d7 | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 8.50e-06 | 193 | 167 | 7 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.50e-06 | 193 | 167 | 7 | 42df7ed37d11fb542b4d1d714b6f87ae8e1396a6 | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_granulocytic|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.50e-06 | 193 | 167 | 7 | e1855cff9a6bcfda9188b9fdf6c9d698405da990 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.50e-06 | 193 | 167 | 7 | f42a0f02ed00fe1bb833ff0a0640d9131bca89bd | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.80e-06 | 194 | 167 | 7 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.80e-06 | 194 | 167 | 7 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 8.80e-06 | 194 | 167 | 7 | 756082a0f5953b52229bb60d40b84701cb6cb23d | |
| ToppCell | (5)_Epithelial_cells-(5)_Epi_basal|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 8.80e-06 | 194 | 167 | 7 | b887b2ff19b76bd93c67f9a24762efae816efd45 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.80e-06 | 194 | 167 | 7 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.09e-06 | 195 | 167 | 7 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.40e-06 | 196 | 167 | 7 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e | |
| ToppCell | Severe_COVID-19-Epithelial-Ciliated|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 9.40e-06 | 196 | 167 | 7 | 1cdef976a754c90d18b6149d367bd64e6e99b0a9 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.40e-06 | 196 | 167 | 7 | 69f5081e06d84ec1d9695762df801a9d0df1984b | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.40e-06 | 196 | 167 | 7 | 686a5a0ddb00929842c1c98445c59edfcc9a8a04 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.40e-06 | 196 | 167 | 7 | 67aefc480714e4b8c9ae53c036efdc07ec6f94af | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.40e-06 | 196 | 167 | 7 | ca56311edc6788e032e7635fa69b1e07035202b5 | |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.40e-06 | 196 | 167 | 7 | d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.72e-06 | 197 | 167 | 7 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.72e-06 | 197 | 167 | 7 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | Control_saline-Hematopoietic_Lymphocytic-Lymphocytic_NK/T|Control_saline / Treatment groups by lineage, cell group, cell type | 1.00e-05 | 198 | 167 | 7 | 9663cf0c8296d3a7b0329cb725ccceeea7849cbc | |
| ToppCell | proximal-Epithelial-Differentiating_Basal-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.04e-05 | 199 | 167 | 7 | c607346f60e5997e757e5a31cab412ab3734377b | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo-neutrophil-myelocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.04e-05 | 199 | 167 | 7 | a1635a52318be0423f8e4fc03d971c28cd22b57e | |
| ToppCell | LPS_anti-TNF-Epithelial_airway|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.04e-05 | 199 | 167 | 7 | 6aca164bbbb961f34b1e6f1857f91ade5c059405 | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.04e-05 | 199 | 167 | 7 | 60919c2af31d39a2d36d7bc432e43dab2a4e05fb | |
| ToppCell | proximal-3-Epithelial-Differentiating_Basal|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.04e-05 | 199 | 167 | 7 | 12e07084fc2d5d4c418df564ccc0e132b056e549 | |
| ToppCell | proximal-Epithelial-Differentiating_Basal|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.04e-05 | 199 | 167 | 7 | 96a89a2578fad9a99c52d2cf9e26e06516a96568 | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.07e-05 | 200 | 167 | 7 | cf191104484bfb2b9f87de416b9453135f8833c1 | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Myeloid-Dendritic_cells-pDC|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.07e-05 | 200 | 167 | 7 | 6a34e07e6d77fe3fdd9ff44c4b1e46a023f6d6a2 | |
| ToppCell | LPS_IL1RA-Epithelial_airway|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.07e-05 | 200 | 167 | 7 | a5ae33dd4dc1ff6e1a1eec22c4d523d5ab657607 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.07e-05 | 200 | 167 | 7 | 72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.07e-05 | 200 | 167 | 7 | da12821e8a0657869ca0f75d351cce2d7605a505 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Cilia-bearing_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.07e-05 | 200 | 167 | 7 | 177f9ad8dd8635394c575a2b30140184df0bd51e | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 1.21e-05 | 135 | 167 | 6 | ae2d3a42e567b5bade304c0caa497eb725be3565 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 1.89e-05 | 146 | 167 | 6 | c55f1bdb6ac43b4118cb27ea7c879527e1afcbab | |
| ToppCell | PND07-Immune-Immune_Myeloid-DC-cDC2|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.12e-05 | 149 | 167 | 6 | 32e0be7da42d26956683b21a1e7ae6915e4c16fb | |
| ToppCell | Striatum-Hematopoietic|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.64e-05 | 155 | 167 | 6 | 12301d823338bf829475905c66c5f08f7159d29f | |
| ToppCell | P15-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.02e-05 | 167 | 167 | 6 | 5c3d0763f73628c71c71f9883556bb4f1639f3cc | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.02e-05 | 167 | 167 | 6 | 942134bbabe9972fae80cbc4ed4e94da52f55dc3 | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.15e-05 | 168 | 167 | 6 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.29e-05 | 169 | 167 | 6 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | Bac-SEP-Lymphocyte-B-B_memory|Bac-SEP / Disease, Lineage and Cell Type | 4.43e-05 | 170 | 167 | 6 | 86db153984437ef1447eae8ef30a40be0925ffd5 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-05 | 171 | 167 | 6 | b54d9d6b03c9c6f28a71cf2ed2bfa9a335bba949 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-05 | 171 | 167 | 6 | 9d825a2e799421af4f2cf4f4dc8e239b5d00476d | |
| ToppCell | facs-Thymus-Flowthrough-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-05 | 172 | 167 | 6 | 438d2e7f1897668a14d85ca70722e5d0102606dc | |
| ToppCell | facs-Thymus-Flowthrough-3m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-05 | 172 | 167 | 6 | 356a66cd9303470e427005cc67fdd22a2c4bf971 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-05 | 172 | 167 | 6 | 46fadeee483fdf8402df92ec98575a09c6c15b16 | |
| ToppCell | facs-Aorta-Heart-3m-Myeloid|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.89e-05 | 173 | 167 | 6 | 513b4d31bcfb269556c6b4cc389865fb12e52c4f | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.89e-05 | 173 | 167 | 6 | 869da6a65d1b9b7529c666ec44e3c8ddec2ea408 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.89e-05 | 173 | 167 | 6 | 0672bd8a4a9d18af343d01f09253fb3388896c10 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.89e-05 | 173 | 167 | 6 | 870e091ec30be01a900e1cb8b9ef1880e3b7b50d | |
| ToppCell | Mesenchymal_cells-Osteo-CAR|Mesenchymal_cells / Lineage and Cell class | 5.05e-05 | 174 | 167 | 6 | 430e3cd61bc2a471959faa40e817aa4dd7d82d28 | |
| ToppCell | 18-Distal-RBC|Distal / Age, Tissue, Lineage and Cell class | 5.21e-05 | 175 | 167 | 6 | cc476b4244442418b8f21721a82a36209b556b36 | |
| ToppCell | 18-Distal-RBC-RBC|Distal / Age, Tissue, Lineage and Cell class | 5.21e-05 | 175 | 167 | 6 | 7130b816e0c02309c161d8e9ad7cb4bc2469e251 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.21e-05 | 175 | 167 | 6 | 1ea6cf9da26601646f57fa14d558a5e9e1f0b345 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.38e-05 | 176 | 167 | 6 | 5914e7635474e7cf24d446bdb1423bc0807ee9c6 | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_macrophage_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.38e-05 | 176 | 167 | 6 | 98176bf3c961d5262593e2d5d002836adb010e13 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Monocytes,_Macrophages|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.55e-05 | 177 | 167 | 6 | cdad5a2f672a7f07c05669bfcaf1ec74defd3de7 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.55e-05 | 177 | 167 | 6 | 991ae76bb615392d84aeb89886148fa42c1c649c | |
| ToppCell | Posterior_cortex-Hematopoietic|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.73e-05 | 178 | 167 | 6 | ea9e4f461dda34c0ebc707d7dbefc7a49ce5bb55 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 5.91e-05 | 179 | 167 | 6 | e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d | |
| ToppCell | Posterior_cortex-Hematopoietic-MICROGLIA|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.91e-05 | 179 | 167 | 6 | 5122fc794509492afde4af8b1b76d51e3070ef05 | |
| ToppCell | LPS_only-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.91e-05 | 179 | 167 | 6 | dc03b9045510eb1bb934329646bb92dd06890ce9 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.91e-05 | 179 | 167 | 6 | ce95b601bf17ae8167d382a105384b9e65e9407f | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-Zbtb32+_B_cell-Zbtb32+_B_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.09e-05 | 180 | 167 | 6 | d8135f73a89b97168f2048258f4648e23536ece4 | |
| ToppCell | LPS-IL1RA-Myeloid-Monocytes,_Macrophages|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.09e-05 | 180 | 167 | 6 | 41896546cd1cc458e08c0d4e19aa4860e5d4fcd6 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-Zbtb32+_B_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.09e-05 | 180 | 167 | 6 | c12c1cc206f7e63e5722471bd3eb84caddb84129 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.09e-05 | 180 | 167 | 6 | 6ac62bf1251978c8c12e715f7b73144fca619794 | |
| ToppCell | LPS-IL1RA-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.09e-05 | 180 | 167 | 6 | 97241f62ee133dcb0d4855ffda5dd1349de9f7b2 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.28e-05 | 181 | 167 | 6 | 6a6bd8e020cb0929b6ecdcb55d467ad24fecfaf0 | |
| Drug | 1,4-benzodiazepine | 8.23e-07 | 11 | 164 | 4 | CID000148431 | |
| Drug | PNU-0251126 [267429-19-6]; Down 200; 1uM; PC3; HT_HG-U133A | FAM234B WDR33 NSD2 ENPP4 NUBPL ERN2 FEM1B SHPK TMEM209 CLEC16A | 1.73e-06 | 197 | 164 | 10 | 7390_DN |
| Drug | Dyclonine hydrochloride [536-43-6]; Down 200; 12.2uM; PC3; HT_HG-U133A | 1.98e-06 | 200 | 164 | 10 | 7261_DN | |
| Drug | phenolphthalin | 3.63e-06 | 5 | 164 | 3 | CID000066494 | |
| Drug | Amobarbital | 3.63e-06 | 5 | 164 | 3 | ctd:D000654 | |
| Drug | lorcaserin | 7.22e-06 | 6 | 164 | 3 | ctd:C506658 | |
| Drug | C1 11-32 | 7.34e-06 | 18 | 164 | 4 | CID000443077 | |
| Drug | C11131 | 7.34e-06 | 18 | 164 | 4 | CID000443076 | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 8.15e-06 | 185 | 164 | 9 | 5585_DN | |
| Drug | T4-G | 9.24e-06 | 19 | 164 | 4 | CID000152424 | |
| Drug | AC1L1OBF | 1.15e-05 | 20 | 164 | 4 | CID000032736 | |
| Drug | ranirestat | 1.26e-05 | 7 | 164 | 3 | ctd:C115070 | |
| Drug | Bromocryptine mesylate [22260-51-1]; Down 200; 5.4uM; PC3; HT_HG-U133A | 1.35e-05 | 197 | 164 | 9 | 4604_DN | |
| Drug | Deltaline [6836-11-9]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 1.35e-05 | 197 | 164 | 9 | 6026_DN | |
| Drug | Sulfamethoxazole [723-46-6]; Down 200; 15.8uM; PC3; HT_HG-U133A | 1.41e-05 | 198 | 164 | 9 | 7366_DN | |
| Drug | Pyrantel tartrate [33401-94-4]; Down 200; 11.2uM; PC3; HT_HG-U133A | SLC35C2 EFCAB14 NDUFB8 FEM1B PCNX1 IL17RA CFAP44 DNMBP CLEC16A | 1.41e-05 | 198 | 164 | 9 | 2097_DN |
| Drug | estriol-16-glucuronide | 1.41e-05 | 21 | 164 | 4 | CID000122281 | |
| Drug | estradiol-3-glucuronide | 2.07e-05 | 23 | 164 | 4 | CID000066651 | |
| Drug | Hymecromone | 2.92e-05 | 25 | 164 | 4 | ctd:D006923 | |
| Drug | scopoletin | 2.97e-05 | 50 | 164 | 5 | CID005280460 | |
| Drug | 7-ethoxycoumarin | 3.72e-05 | 86 | 164 | 6 | CID000035703 | |
| Drug | oxazepam | 3.96e-05 | 53 | 164 | 5 | CID000004616 | |
| Drug | licochalcone A | 4.00e-05 | 27 | 164 | 4 | ctd:C070840 | |
| Drug | L-idaro-1,4-lactone | 4.64e-05 | 28 | 164 | 4 | CID000078997 | |
| Drug | 3 alpha,6 alpha-dihydroxy-5 beta-cholanoic acid | 5.36e-05 | 29 | 164 | 4 | CID000006747 | |
| Drug | 7-hydroxycoumarin glucuronide | 5.36e-05 | 29 | 164 | 4 | CID000125641 | |
| Drug | 7-methoxycoumarin | 5.64e-05 | 57 | 164 | 5 | CID000010748 | |
| Drug | phenolphthalein | 6.14e-05 | 58 | 164 | 5 | CID000004764 | |
| Drug | tolcapone | 6.14e-05 | 30 | 164 | 4 | CID004659569 | |
| Drug | Mepenzolate bromide [76-90-4]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 7.58e-05 | 191 | 164 | 8 | 6024_DN | |
| Drug | NNAL | 7.97e-05 | 32 | 164 | 4 | CID000104856 | |
| Drug | Prilocaine hydrochloride [1786-81-8]; Down 200; 15.6uM; PC3; HT_HG-U133A | 8.45e-05 | 194 | 164 | 8 | 4284_DN | |
| Drug | Dimethadione [695-53-4]; Down 200; 31uM; PC3; HT_HG-U133A | 8.76e-05 | 195 | 164 | 8 | 4607_DN | |
| Drug | 3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Up 200; 13.8uM; PC3; HT_HG-U133A | 8.76e-05 | 195 | 164 | 8 | 4298_UP | |
| Drug | Colchicine [64-86-8]; Down 200; 10uM; PC3; HT_HG-U133A | 8.76e-05 | 195 | 164 | 8 | 4614_DN | |
| Drug | R(-)-Denopamine | 9.02e-05 | 33 | 164 | 4 | CID000003818 | |
| Drug | AC1Q6OQG | 9.02e-05 | 33 | 164 | 4 | CID000009686 | |
| Drug | BP-3,6-quinol | 9.02e-05 | 33 | 164 | 4 | CID000119292 | |
| Drug | Metyrapone [54-36-4]; Down 200; 17.6uM; PC3; HT_HG-U133A | 9.41e-05 | 197 | 164 | 8 | 4606_DN | |
| Drug | U-62066 [87151-85-7]; Down 200; 1uM; PC3; HT_HG-U133A | 9.41e-05 | 197 | 164 | 8 | 4553_DN | |
| Drug | Deptropine citrate [2169-75-7]; Down 200; 7.6uM; PC3; HT_HG-U133A | 9.41e-05 | 197 | 164 | 8 | 5118_DN | |
| Drug | ezetimibe | 9.68e-05 | 147 | 164 | 7 | CID000150311 | |
| Drug | 2-Aminobenzenesulfonamide [3306-62-5]; Up 200; 23.2uM; MCF7; HT_HG-U133A | 9.74e-05 | 198 | 164 | 8 | 5422_UP | |
| Drug | Lactobionic acid [96-82-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 9.74e-05 | 198 | 164 | 8 | 3246_DN | |
| Drug | thioridazine hydrochloride; Down 200; 10uM; HL60; HT_HG-U133A | 9.74e-05 | 198 | 164 | 8 | 6189_DN | |
| Drug | Urapidil hydrochloride [64887-14-5]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 9.74e-05 | 198 | 164 | 8 | 6455_UP | |
| Drug | Sulfamethoxypyridazine [80-35-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 9.74e-05 | 198 | 164 | 8 | 3609_DN | |
| Drug | Heptaminol hydrochloride [543-15-7]; Down 200; 22uM; PC3; HT_HG-U133A | 9.74e-05 | 198 | 164 | 8 | 1825_DN | |
| Drug | Nalidixic acid sodium salt hydrate; Down 200; 14.6uM; PC3; HT_HG-U133A | 1.01e-04 | 199 | 164 | 8 | 3668_DN | |
| Drug | AC1L45AJ | 1.02e-04 | 34 | 164 | 4 | CID000200882 | |
| Drug | Laudanosine (R,S) [1699-51-0]; Up 200; 11.2uM; HL60; HG-U133A | 1.04e-04 | 200 | 164 | 8 | 1741_UP | |
| Drug | AC1NOWCJ | 1.14e-04 | 35 | 164 | 4 | CID005120112 | |
| Drug | 3-[(3S,5R,10S,13R,14S,17R)-3-[(2S,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one | 1.14e-04 | 35 | 164 | 4 | CID010436171 | |
| Drug | estrone-3-glucuronide | 1.14e-04 | 35 | 164 | 4 | CID000115255 | |
| Drug | taurin | 1.26e-04 | 14 | 164 | 3 | CID000211707 | |
| Drug | Meldola | 1.32e-04 | 68 | 164 | 5 | CID000081507 | |
| Drug | TC-3 | 1.41e-04 | 69 | 164 | 5 | CID000398798 | |
| Drug | l-borneol | 1.42e-04 | 37 | 164 | 4 | CID000010049 | |
| Drug | baciphelacin | 1.51e-04 | 70 | 164 | 5 | CID000171612 | |
| Drug | oxazepam glucuronide | 1.54e-04 | 3 | 164 | 2 | ctd:C026256 | |
| Drug | 5 alpha-dihydroaldosterone | 1.54e-04 | 3 | 164 | 2 | CID003036614 | |
| Drug | carvedilol | 1.70e-04 | 161 | 164 | 7 | CID000002585 | |
| Disease | X-19141 measurement | 6.02e-07 | 13 | 162 | 4 | EFO_0800799 | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 5.59e-06 | 7 | 162 | 3 | C0751337 | |
| Disease | X-24947 measurement | 5.93e-06 | 22 | 162 | 4 | EFO_0800910 | |
| Disease | deoxycholic acid glucuronide measurement | 8.92e-06 | 8 | 162 | 3 | EFO_0800575 | |
| Disease | plasma clozapine-to-N-desmethylclozapine ratio measurement | 1.33e-05 | 9 | 162 | 3 | EFO_0600040 | |
| Disease | metabolite measurement | SLC24A5 WDFY4 SYNE2 UGT2B4 UGT2B7 UGT2B15 UGT2B17 LOXL4 NQO2 DNMBP TTC38 PNP | 6.63e-05 | 560 | 162 | 12 | EFO_0004725 |
| Disease | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy | 8.95e-05 | 3 | 162 | 2 | cv:C1846574 | |
| Disease | cholic acid glucuronide measurement | 8.95e-05 | 3 | 162 | 2 | EFO_0800574 | |
| Disease | androsterone glucuronide measurement | 1.73e-04 | 20 | 162 | 3 | EFO_0800317 | |
| Disease | X-25937 measurement | 1.78e-04 | 4 | 162 | 2 | EFO_0800937 | |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 1.78e-04 | 4 | 162 | 2 | cv:CN293514 | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 2.96e-04 | 5 | 162 | 2 | C1450051 | |
| Disease | centronuclear myopathy 1 (implicated_via_orthology) | 2.96e-04 | 5 | 162 | 2 | DOID:0111223 (implicated_via_orthology) | |
| Disease | microcytic anemia (implicated_via_orthology) | 2.96e-04 | 5 | 162 | 2 | DOID:11252 (implicated_via_orthology) | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 2.96e-04 | 5 | 162 | 2 | C0410190 | |
| Disease | Charcot-Marie-Tooth disease dominant intermediate B (implicated_via_orthology) | 2.96e-04 | 5 | 162 | 2 | DOID:0110197 (implicated_via_orthology) | |
| Disease | Emery-Dreifuss muscular dystrophy | 4.43e-04 | 6 | 162 | 2 | cv:C0410189 | |
| Disease | cardiovascular measurement | 4.43e-04 | 6 | 162 | 2 | EFO_0004298 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 4.43e-04 | 6 | 162 | 2 | C0410189 | |
| Disease | MITOCHONDRIAL COMPLEX I DEFICIENCY | 5.91e-04 | 30 | 162 | 3 | C1838979 | |
| Disease | vanillylmandelate (VMA) measurement | 6.18e-04 | 7 | 162 | 2 | EFO_0800119 | |
| Disease | X-24574 measurement | 6.18e-04 | 7 | 162 | 2 | EFO_0800897 | |
| Disease | X-24418 measurement | 6.18e-04 | 7 | 162 | 2 | EFO_0800879 | |
| Disease | eye movement measurement | 8.21e-04 | 8 | 162 | 2 | EFO_0007699 | |
| Disease | atopic asthma | 8.35e-04 | 199 | 162 | 6 | EFO_0010638 | |
| Disease | Colorectal Neoplasms | 8.82e-04 | 277 | 162 | 7 | C0009404 | |
| Disease | response to simvastatin, PCSK9 protein measurement | 1.05e-03 | 9 | 162 | 2 | EFO_0006899, GO_1903491 | |
| Disease | X-12844 measurement | 1.05e-03 | 9 | 162 | 2 | EFO_0021339 | |
| Disease | vitamin D deficiency | 1.10e-03 | 37 | 162 | 3 | EFO_0003762 | |
| Disease | 4-androsten-3alpha,17alpha-diol monosulfate (3) measurement | 1.31e-03 | 10 | 162 | 2 | EFO_0022090 | |
| Disease | mitochondrial complex I deficiency (implicated_via_orthology) | 1.31e-03 | 10 | 162 | 2 | DOID:0060536 (implicated_via_orthology) | |
| Disease | chronic fatigue syndrome (is_marker_for) | 1.31e-03 | 10 | 162 | 2 | DOID:8544 (is_marker_for) | |
| Disease | liver fibrosis measurement | 1.31e-03 | 86 | 162 | 4 | EFO_0010576 | |
| Disease | DNA repair protein RAD51 homolog 4 measurement | 1.59e-03 | 11 | 162 | 2 | EFO_0801531 | |
| Disease | peanut allergy measurement, parental genotype effect measurement | 1.59e-03 | 11 | 162 | 2 | EFO_0005939, EFO_0007017 | |
| Disease | Uterine leiomyoma | 1.61e-03 | 91 | 162 | 4 | HP_0000131 | |
| Disease | testosterone measurement | DCDC1 DNAH2 ZC3HC1 REN ABCA8 ZC3H7A SLC20A2 SYNE2 UGT2B4 UGT2B7 DNM3 UGT2B15 UGT2B17 KLHL8 HSD17B2 DNMBP | 1.81e-03 | 1275 | 162 | 16 | EFO_0004908 |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 1.91e-03 | 12 | 162 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | collagen disease (implicated_via_orthology) | 1.91e-03 | 12 | 162 | 2 | DOID:854 (implicated_via_orthology) | |
| Disease | 5alpha-androstan-3beta,17beta-diol monosulfate (2) measurement | 1.91e-03 | 12 | 162 | 2 | EFO_0800291 | |
| Disease | rhinitis (is_marker_for) | 2.07e-03 | 46 | 162 | 3 | DOID:4483 (is_marker_for) | |
| Disease | developmental and epileptic encephalopathy (implicated_via_orthology) | 2.25e-03 | 13 | 162 | 2 | DOID:0112202 (implicated_via_orthology) | |
| Disease | androstenediol (3alpha, 17alpha) monosulfate (3) measurement | 2.25e-03 | 13 | 162 | 2 | EFO_0800293 | |
| Disease | 5alpha-androstan-3alpha,17alpha-diol monosulfate measurement | 2.61e-03 | 14 | 162 | 2 | EFO_0800283 | |
| Disease | central nervous system disease (implicated_via_orthology) | 3.42e-03 | 16 | 162 | 2 | DOID:331 (implicated_via_orthology) | |
| Disease | neuroblastoma | 3.89e-03 | 116 | 162 | 4 | EFO_0000621 | |
| Disease | HMG CoA reductase inhibitor use measurement | 3.97e-03 | 189 | 162 | 5 | EFO_0009932 | |
| Disease | Libman-Sacks Disease | 4.02e-03 | 58 | 162 | 3 | C0242380 | |
| Disease | Endometrial Neoplasms | 4.02e-03 | 58 | 162 | 3 | C0014170 | |
| Disease | alkaline phosphatase measurement | ERN1 GRIK5 SLC2A4 KIRREL3 LIMS1 ST3GAL6 ABCA6 SURF6 UGT2B4 UGT2B7 UGT2B15 UGT2B17 RIC1 | 4.08e-03 | 1015 | 162 | 13 | EFO_0004533 |
| Disease | 5alpha-androstan-3alpha,17beta-diol monosulfate (1) measurement | 4.33e-03 | 18 | 162 | 2 | EFO_0800288 | |
| Disease | response to antipsychotic drug | 4.42e-03 | 60 | 162 | 3 | GO_0097332 | |
| Disease | disease progression measurement | 4.63e-03 | 61 | 162 | 3 | EFO_0008336 | |
| Disease | free androgen index | 4.74e-03 | 374 | 162 | 7 | EFO_0007005 | |
| Disease | etiocholanolone glucuronide measurement | 4.82e-03 | 19 | 162 | 2 | EFO_0800362 | |
| Disease | angiopoietin-1 receptor measurement | 4.82e-03 | 19 | 162 | 2 | EFO_0010600 | |
| Disease | Arsenic Induced Polyneuropathy | 4.85e-03 | 62 | 162 | 3 | C0751852 | |
| Disease | Arsenic Encephalopathy | 4.85e-03 | 62 | 162 | 3 | C0751851 | |
| Disease | Arsenic Poisoning | 4.85e-03 | 62 | 162 | 3 | C0311375 | |
| Disease | Arsenic Poisoning, Inorganic | 4.85e-03 | 62 | 162 | 3 | C0274861 | |
| Disease | Nervous System, Organic Arsenic Poisoning | 4.85e-03 | 62 | 162 | 3 | C0274862 | |
| Disease | cutaneous melanoma, hair color | 4.85e-03 | 62 | 162 | 3 | EFO_0000389, EFO_0003924 | |
| Disease | uterine fibroid | 4.94e-03 | 199 | 162 | 5 | EFO_0000731 | |
| Disease | renal system measurement | 5.33e-03 | 20 | 162 | 2 | EFO_0004742 | |
| Disease | selenium measurement, response to dietary selenium supplementation | 5.33e-03 | 20 | 162 | 2 | EFO_0006331, EFO_0600021 | |
| Disease | Hemorrhage | 5.33e-03 | 20 | 162 | 2 | C0019080 | |
| Disease | Fetal Growth Retardation | 5.33e-03 | 20 | 162 | 2 | C0015934 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EFLRGSIRTWIGQKM | 2286 | Q9HCE0 | |
| EFQMRLLWGSKGAQV | 781 | O75815 | |
| EVAAAIKIQAMWRGT | 906 | Q8N7X0 | |
| GQMREVELGWGKVLL | 81 | Q96NN9 | |
| KVVVGIVLWNIFNRM | 571 | O95831 | |
| VTQMKWRLQEGRGEA | 86 | Q9BX10 | |
| MWQAIQAVVKNTERG | 1451 | Q8N139 | |
| MGSQNRWLIDNGVTK | 1321 | Q6XZF7 | |
| GWSQIMFRKQVILGN | 346 | Q6MZZ7 | |
| EKIQERVMNNLGTWI | 391 | O95376 | |
| VQFLKNLNLGGAMIW | 346 | Q15782 | |
| MIRVKKQVWVGSRGL | 1126 | A2RUS2 | |
| NGLVLWVAGLKMQRT | 41 | Q16581 | |
| KQGGTALVWVPRMVN | 511 | Q96MT7 | |
| ESGEMGLNKVWINIT | 141 | O75071 | |
| IGLIMLIGWSQGKQL | 306 | O75185 | |
| RWEVVGKNLLAMVIQ | 1726 | Q8IZY2 | |
| CIQIRGQILQKLGMW | 196 | Q96QP1 | |
| QMWELSAVARVELKG | 341 | P08133 | |
| GQRVESIGQWQKVME | 796 | Q9HCE9 | |
| LIGNREWMIRNGLVI | 1181 | Q04656 | |
| KLLVIGTQDGIMAVW | 881 | Q149M9 | |
| RLSKAEILGNWNMFV | 296 | Q96D15 | |
| VKVKLQMWDTAGQER | 111 | Q9ULW5 | |
| LIHWEGMTNGRKAIN | 166 | Q4ADV7 | |
| GARRWINIDGKTMDI | 361 | O75916 | |
| WVVRVQAAKLLGSME | 296 | Q96HW7 | |
| RQWRMKAEVTGTQIG | 441 | P20702 | |
| MRRAKVLDWGLQEQL | 151 | Q9NPH2 | |
| LLVIQWNIRAFMGVK | 811 | P12883 | |
| VMWNRTQVVGILVGL | 251 | Q7Z419 | |
| TQLTIIMGGKAIWNN | 606 | Q4KMQ2 | |
| IMGGKAIWNNIQEVL | 611 | Q4KMQ2 | |
| GSWIRTVQNKLQKIM | 241 | Q96PD6 | |
| GGWTEQTQQEIKLME | 1611 | M0R2J8 | |
| SEAGVMTWVGRQKQE | 421 | Q96F46 | |
| NQTMGWGEKAIEIRS | 1171 | O95819 | |
| EGRVEVLMNRQWGTV | 321 | Q96JB6 | |
| QTVGKMVLNDWQRGR | 441 | Q13823 | |
| QGVGWLNMKKVRRLL | 956 | Q8WXG6 | |
| KTEGLIVWMGIAQNE | 3011 | Q5T1H1 | |
| GVAISWRKQLVNMLL | 741 | Q2M2H8 | |
| RIGFQSLIQKEWVMG | 416 | Q9C0I1 | |
| IISQWLGRKRAMLVN | 101 | P14672 | |
| IRKGWLTINNIGIMK | 521 | Q05193 | |
| IMRANGLGSIWKENT | 146 | Q5VTL7 | |
| VLLGGWILFVMRQQQ | 441 | Q76MJ5 | |
| LAGALEKMVNIWQVN | 3501 | Q15751 | |
| RGMLQNRVLLWKEQS | 206 | Q6UXY1 | |
| LIKWRAAIVVNGHGM | 206 | Q9UK73 | |
| LLVRVRNGKWGGVEM | 541 | P52789 | |
| VIRKGWLTISNIGIM | 526 | Q9UQ16 | |
| GKLGENMILKRAAWV | 191 | P43897 | |
| GALKLGEEQQRQQWM | 556 | Q9H1B7 | |
| MGSQTLQILRQGVWA | 1 | Q96RV3 | |
| MGSQVLQILRQGVWA | 1 | Q9H6A9 | |
| KWIEVKEMGQRRAGN | 486 | Q9P2G9 | |
| GEQTEKMWQRLKGIL | 21 | P54750 | |
| LKMLGLWENLNVIIT | 221 | Q9Y6X5 | |
| VVSKLSLRWALMEGQ | 576 | A2RU67 | |
| GKLRAQWEMGIVQAE | 316 | O96028 | |
| AMQGLTRFEAWNIIK | 1291 | Q14005 | |
| VGKSMLLQRLQSLWA | 206 | Q9Y239 | |
| AVQQLAKVMGWQVLS | 536 | Q9NVC6 | |
| MAVARAGVLGVQWLQ | 1 | O95169 | |
| GDIVKVTRMNINGQW | 261 | P46109 | |
| RKGMVAAWSQRLQTI | 201 | P16083 | |
| VMLRGSGIQWDLRKT | 291 | O75306 | |
| MKIWQASNGELRRVL | 116 | Q9BRP4 | |
| WVGDSQVMLVRKGQA | 346 | Q8WY54 | |
| LIMIAGGNQSILLWI | 361 | Q9UII4 | |
| ERLRQMGSWLKVNGE | 351 | Q9BTY2 | |
| WKNMLTESLVALQRG | 571 | Q96EP1 | |
| EVMKTRTGSWQVLQR | 381 | Q93033 | |
| QEMNVWLNKLGSAVI | 126 | Q8WWN9 | |
| KGGDVWVVAQNRMTL | 41 | A4D1E9 | |
| LTQNVGLLGLLKWRM | 611 | Q92608 | |
| VWQREGLRKVMHINV | 231 | O75460 | |
| EKRRIMQQWASSLVG | 491 | Q4G0X9 | |
| IVLQLKLGDEMWLQV | 291 | B2RNN3 | |
| KLGDEMWLQVTGGER | 296 | B2RNN3 | |
| WIRQMEGSRLQKLSI | 2536 | Q0VDD8 | |
| MKSWAGLLRILGVVE | 186 | Q8N4S9 | |
| GTLEQIMKDRWINAG | 296 | P27448 | |
| GDSGQGLRMWIKQVL | 31 | Q5VWZ2 | |
| GLRMWIKQVLNQDLT | 36 | Q5VWZ2 | |
| GIWVIAKTLQRAMET | 361 | O75899 | |
| ARVKNWLGNEIEVMV | 741 | O95239 | |
| WNGMIGELISKRADL | 501 | Q9ULK0 | |
| MAVVWKLLREGNVNI | 876 | Q5T7N3 | |
| IVWMKRGSGVVLSNE | 366 | Q8IZU9 | |
| ELQLNIEDMQWGKGV | 501 | Q14831 | |
| NVSENGWLKAVQVLM | 56 | P54852 | |
| MGLGQAAWKEARVFL | 71 | P16930 | |
| IGGIKLRHQQWSLVM | 201 | P22607 | |
| WTGMVGELINRKADL | 481 | Q16478 | |
| RVGWAEQLEGRNKML | 56 | A0A1B0GVR7 | |
| LQSRGMVILQWGKRK | 651 | Q8TB52 | |
| KVAAMLQDRGLWAVI | 151 | P37059 | |
| NGIIVTRGNRWALMI | 3381 | Q9P225 | |
| LNLWQKIRGDLIGMD | 351 | Q8N7B9 | |
| GQEGVKWSELIKIVM | 146 | Q8WUM9 | |
| SLVAIGTKGVQWMEL | 126 | Q08357 | |
| GTKGVQWMELVKIVA | 131 | Q08357 | |
| AVMLGWARQGAFKEL | 266 | O00411 | |
| LRGIQKVAMLVQGNW | 311 | Q9NVU0 | |
| STWKQMGEQRELQEG | 176 | P00491 | |
| VMSAIEKLLRQVDWG | 161 | Q8TB37 | |
| WMGIAFRIQKEALGG | 351 | Q9BUJ2 | |
| GLQEMVQLLEKWILS | 946 | A6NES4 | |
| MWSSKELQGVLRQQG | 711 | Q13835 | |
| LQEVEKWLLQMSGRL | 3931 | Q8NF91 | |
| TGLWAQGRELMKEVT | 4511 | Q8NF91 | |
| LGAMNKSWQILQGLV | 6996 | Q8NF91 | |
| VLKGQAELQMKRIWG | 2681 | Q8WXH0 | |
| EDNIGNQLLRKMGWT | 551 | O15226 | |
| EIRFNNGWMIKIGRG | 196 | Q8WV92 | |
| TNELMRWGLRLQKDV | 546 | Q8TC59 | |
| SNMWARGLGQLIRAK | 2311 | Q5UIP0 | |
| LIKTGVWQIQMKGVS | 261 | P00797 | |
| ALFNGISKWVQLMVL | 196 | Q8IV61 | |
| WQLLSIIVLMGGQQL | 276 | P22732 | |
| QEMLRASGLTQKWVQ | 2056 | Q6ZNJ1 | |
| WLLELLMGDKINTNG | 196 | Q9Y274 | |
| ILDRLGSKVWGQLMD | 296 | Q7Z333 | |
| IQQLQEWGVERVMGS | 416 | Q9UHJ6 | |
| GDRLIWLVKMVNGQE | 391 | P49221 | |
| VQKEGMRKQGLFQWL | 161 | Q9Y253 | |
| MRKQGLFQWLDSLQI | 166 | Q9Y253 | |
| RWEKRTAGVVEKMQQ | 306 | O75683 | |
| EFIIGRVIKAMNNSW | 76 | P48059 | |
| GQLGEAVKRLAEMAW | 1536 | A1L4H1 | |
| MRKTIGGVALWRQQI | 831 | O94911 | |
| VWMIQNGTLIESGII | 101 | P28288 | |
| LIQMVIQGRWLKDSS | 1946 | Q8N3C0 | |
| MQILGVVLTLLGWVN | 6 | P56747 | |
| VGLVALGIWSVMQRN | 46 | Q9P126 | |
| MNWVGGSRSRVLIKQ | 1 | Q86WS4 | |
| WGVVKFAGLLQDMQV | 746 | Q2KHT3 | |
| RLEVGMKNNVKWELN | 171 | Q9BYD2 | |
| MRKVGLWGFQQIESS | 276 | Q86WB0 | |
| ILKWNELNVGDVVMV | 236 | Q96PU4 | |
| DAWGKQLEMLREVGQ | 86 | Q9BZM4 | |
| AWGALEKNGTQLMIR | 521 | Q9NUW8 | |
| SNQIMGWGEKAIEIR | 1291 | Q9UKE5 | |
| FWAVKNVTGRLMVGL | 76 | Q96ET8 | |
| GINMTGKVDRNTIDW | 81 | P51512 | |
| QLAQEIKNLSGWMGR | 426 | Q9ULX5 | |
| RNEFVGLWLGMAKLG | 136 | Q6P1M0 | |
| WMNIKTILDELVQRG | 36 | P06133 | |
| GLRNMIWQTLQKTKD | 456 | C9JQI7 | |
| DGMIRVWNTLSIKNN | 401 | Q8TEQ6 | |
| LWIIFDQNKRQMGSG | 856 | P29144 | |
| IIITGSQDGMVRVWK | 3086 | Q6ZS81 | |
| MQTKGGQTWARRALL | 1 | Q71RS6 | |
| GGIRWTLTQMLLQKA | 176 | Q9NQQ7 | |
| MRIGKEWLDAGNFLI | 126 | Q8IYF3 | |
| LMQQGIKAGDALWLR | 236 | Q86UX7 | |
| QQLDLKMAVRVLWGG | 26 | Q86VD9 | |
| QGGLHIWISENRKMV | 11 | O15195 | |
| RKVVLAWGLLNVSMA | 26 | Q96SK2 | |
| VELKVWIMQNETGIS | 656 | Q8IWR0 | |
| RLQMEGVSVGQRWQD | 301 | Q5R3I4 | |
| FWAVKNVTGRLMVGL | 76 | Q9NYZ1 | |
| WINMKTILEELVQRG | 36 | P54855 | |
| VMEVKLNLNGNWLLT | 291 | Q9C0J8 | |
| WMNIKTILDELIQRG | 36 | P16662 | |
| MQQLEQWIKIQKGRG | 411 | Q9HAU0 | |
| TVQGGVLQGWEMRLE | 101 | Q9BUY5 | |
| WINMKTILEELVQRG | 36 | O75795 | |
| MRAKQLLVAWQDQEG | 611 | Q96FV9 | |
| VKQVLGWIRNGESML | 916 | O75962 | |
| LVHLWMTGARVKNLG | 96 | Q9UKN1 | |
| GNLDGSMRKVLVWQN | 1151 | O75096 | |
| TATIMIQKTVRGWLQ | 766 | Q9ULV0 |